患有酒精使用障碍的患者的渴望和阿坎普罗沙特治疗反应的生物标志物:来自多omics的见解

Ming-Fen Ho1,2, Cheng Zhang3, Brandon J Coombes4

  • 1Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA. ho.mingfen@mayo.edu.

Molecular psychiatry
|February 25, 2026
PubMed
概括

研究人员确定HSD11B1和皮质醇是酒精渴望强度和酒精使用障碍 (AUD) 治疗反应的潜在生物标志物. 这项研究使用了多项OMIC数据,以找到对渴望和治疗成功的客观标记.

相关概念视频

Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.8K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53